Our bodies depend on a set of immune receptors to remove harmful bacteria and control the growth of helpful bacteria in our guts. Genetic changes that alter the function of the receptors can have an adverse effect and result in chronic inflammatory diseases like Crohn’s disease. Catherine Leimkuhler Grimes and Vishnu Mohanan of the University of Delaware researched a Crohn’s-associated immune receptor, NOD2, to figure out how it can lose the ability to respond properly to bacteria. In the process, they identified the involvement of a protective protein called HSP70. Increasing HSP70 levels in kidney, colon and white blood cells appeared to restore NOD2 function. This work represents a first step toward developing drugs to treat Crohn’s disease.
This work was funded in part by an Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) grant.
4 Replies to “Restoring the Function of an Immune Receptor Involved in Crohn’s Disease”
If there are clinical trials and the need for those with Crohn’s disease to be a part
of those trials, I would like to be considered.
I’m interested in doing a clinical trial as well.
For information about participating in NIH clinical trials, visit https://clinicaltrials.gov.
Comments are closed.